David M. Watumull
Financieel Directeur/CFO bij CARDAX, INC.
Profiel
Mr. David M.
Watumull is a Chief Operating Officer at Cardax Pharma, Inc. and a Chief Financial & Operating Officer at Cardax, Inc. Mr. Watumull was previously employed as a Vice President-Operations by Koffee Korner, Inc., a Vice President-Operations & Assistant Secretary by Cardax Pharmaceuticals, Inc., a Manager-Information Technology by Hawaii Biotech, Inc., and a Medical Information Specialist by Aquasearch, Inc. He received his undergraduate degree from the University of Hawai'i at Hilo.
Actieve functies van David M. Watumull
Bedrijven | Functie | Begin |
---|---|---|
CARDAX, INC. | Financieel Directeur/CFO | 01-08-2021 |
Cardax Pharma, Inc.
Cardax Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Cardax, Inc., Cardax Pharma, Inc. is a pharmaceutical company that previously focused on developing a platform of proprietary, exceptionally safe, small molecule compounds for large unmet medical needs where oxidative stress and inflammation play key causative roles. The company is based in Honolulu, HI. The company may seek to monetize its pharmaceutical assets through licensing or sale. Astaxanthin use is supported by hundreds of peer-reviewed papers published in leading medical research journals. The company was founded by David G. Watumull, Samuel F. Lockwood, and David G. Watumull has been the CEO since incorporation. Cardax Pharma was acquired by Koffee Korner, Inc. on February 07, 2014 for $15 million. | Operationeel Directeur | 01-05-2013 |
Eerdere bekende functies van David M. Watumull
Bedrijven | Functie | Einde |
---|---|---|
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Financieel Directeur/CFO | 01-07-2013 |
Koffee Korner, Inc.
Koffee Korner, Inc. Specialty StoresRetail Trade Koffee Korner, Inc. engages in retailing of coffee. The company purchases and roasts high quality whole bean coffees that it sells, along with handcrafted coffee and tea beverages and a variety of fresh food items, through its retail store in Houston, Texas. It products include coffee, tea, ice cream shake and javaccino. The company was founded on July 7, 2003 and is headquartered in Washington Boro, PA. | Operationeel Directeur | 21-02-2014 |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
Aquasearch, Inc. | Corporate Officer/Principal | 01-01-2001 |
Opleiding van David M. Watumull
University of Hawai'i at Hilo | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARDAX, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Health Technology |
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
Aquasearch, Inc. | Finance |
Koffee Korner, Inc.
Koffee Korner, Inc. Specialty StoresRetail Trade Koffee Korner, Inc. engages in retailing of coffee. The company purchases and roasts high quality whole bean coffees that it sells, along with handcrafted coffee and tea beverages and a variety of fresh food items, through its retail store in Houston, Texas. It products include coffee, tea, ice cream shake and javaccino. The company was founded on July 7, 2003 and is headquartered in Washington Boro, PA. | Retail Trade |
Cardax Pharma, Inc.
Cardax Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Cardax, Inc., Cardax Pharma, Inc. is a pharmaceutical company that previously focused on developing a platform of proprietary, exceptionally safe, small molecule compounds for large unmet medical needs where oxidative stress and inflammation play key causative roles. The company is based in Honolulu, HI. The company may seek to monetize its pharmaceutical assets through licensing or sale. Astaxanthin use is supported by hundreds of peer-reviewed papers published in leading medical research journals. The company was founded by David G. Watumull, Samuel F. Lockwood, and David G. Watumull has been the CEO since incorporation. Cardax Pharma was acquired by Koffee Korner, Inc. on February 07, 2014 for $15 million. | Health Technology |